A comparison of pathophysiological changes during hypobaric and normobaric hypoxia in rats

Respiration

Volumn 63, Issue 4, 1996, Pages 217-222

  Sheedy, W ^a   Thompson, J S ^a   Morice, A H ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Atrial natriuretic peptide; Chronic hypoxia; Hypobaric hypoxia; Normobaric hypoxia; Pulmonary hypertension

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; CONTROLLED STUDY; HEART RIGHT VENTRICLE HYPERTROPHY; HEMATOCRIT; HORMONE BLOOD LEVEL; HYPOBARISM; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; TIME; WEIGHT GAIN;

ANIMALS; ANOXIA; ATMOSPHERIC PRESSURE; ATRIAL NATRIURETIC FACTOR; ELASTIC TISSUE; HEMATOCRIT; HYPERTENSION, PULMONARY; MALE; MYOCARDIUM; ORGAN SIZE; PULMONARY ARTERY; RATS; RATS, WISTAR; WEIGHT GAIN;

EID: 0029995775     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000196548     Document Type: Article

References (30)

1. Ravcnhil TH: Some experience of mountain sickness in the Andes. J Trop Med Hyg 1913: 16:314-320.
2. Monge CC, Whittembury J: Chronic mountain sickness. Johns Hopkins Med J 1976; 139:87-89.
3. Leach E. Howard P, Barer GR: Resolution of hypoxic changes in the heart and pulmonary arterioles of rats during intermittent correction of hypoxia. Clin Sci Mol Med 1977:52:153-162.
4. Zhao L. Winter RJ, Krausz T, Hughes JM: Effects of continuous infusion of atrial natriuretic peptide on the pulmonary hypertension induced by chronic hypoxia in rats. Clin Sci 1991;81:379-385.
5. Abraham AS, Kay JM. Cole RB, Pincock AC: Haemodynamic and pathological study of the effect of chronic hypoxia and subsequent recovery of the heart and pulmonary vasculature of the rat. Cardiovasc Res 1971:5:95-102.
6. Davies P, Maddola F, Reid L: Effects of chronic hypoxia on structure and reactivity of rat lung microvessels. J Appl Physiol 1985:58: 795-801.
7. Hunter C, Barer GR, Shaw JW. Clegg EJ: Growth of the heart and lungs in hypoxic rodents: A model of human hypoxic disease. Clin Sci Mol Med 1974;46:375-391.
8. Ono S, Westcoll JY. Voelkel NF: PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J Appl Physiol 1992;73:1084-1092.
9. Reid LM: The pulmonary circulation: Remodeling in growth and disease. Am Rev Rcspir Dis 1979;119:531-546.
10. Rabinovitch M, Gamble W. Nadas AS. Mict-tinen OS, Reid L: Rat pulmonary circulation after chronic hypoxia: Haemodynamic and structural features. Am J Physiol 1979,236: 818-827.
11. Zhao L, Crawley DE, Hughes JMB, Evans TW. Winter RJD: Endothelium-derived relaxing factor activity in rat lung during hypoxic pulmonary vascular remodeling. J Appl Physiol 1993:74:1061-1065.
12. Naeye RL: Hypoxia, effects on the pulmonary vascular bed. Med Thorac 1962:19:494-501.
13. Winter RJ, Melcagros L, Pcrvcz S. Jamal H, Krausz T. Polak JM, Bloom SR: Atrial natriuretic peptide levels in plasma and in cardiac tissues after chronic hypoxia in rats. Clin Sci 1989:76:95-101.
14. Morice AH, Pepke-Zaba J. Brown MJ. Thomas PS. Higenbottam TW: Atrial natriuretic peptide in primary pulmonary hypertension. Eur RespirJ 1990;3:910-913.
15. Stewart AG. Bardslev PA, Baudouin SV, Waterhouse JC, Thompson JS. Morice AH, Howard P: Changes in atrial natriuretic peptide concentrations during intravenous saline infusion in hypoxic cor pulmonale. Thorax 1991: 46:829-834.
16. Winter RJ, Davidson AC, Treacher D. Rudd RM. Anderson JV, Meleagros L, Bloom SR: Atrial natriuretic peptide concentrations in hypoxic secondary’ pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen. Thorax 1989;44:58-62.
17. Cryer A, Bartley W: The design and use of a hypoxic chamber for small animals. Lab Pract 1974;23:713-715.
18. von Euler US, Liljestrand G: Observation on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 1946;12:301-320.
19. Naeye RL: Pulmonary vascular changes with chronic unilateral pulmonary hypoxia. Circ Res 1965;17:160-167.
20. Sulkin NM. Jones G: An experimental chamber tor long term studies of chronic hypoxia in small animals. J Appl Physiol 1965;20:346-348.
21. Thompson JS. Shecdy W, Moricc AH: The effects of the neutral endopeptidase inhibitor. SCH 42495. on the cardiovascular remodelling secondary to chronic hypoxia in rats. Clin Sci 1994;87:109-114.
22. Jin H. Yang RH, Chen YF. Jackson RM. Opa-ril S: Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia. J Clin Invest 1990;85:115-120.
23. Suggett AJ. Barer GR: Experimental prevention of hypoxic pulmonary hypertension in animals by drugs. Eur Heart J 1988:9(suppl J): 13-18.
24. Hcrget J. Palecek F: Experimental chronic pulmonary hypertension. Int Rev Exp Pathol 1978:18:347-406.
25. McKenzie JC. Tanaka I. Inagami T. Misono KS. Klein RM: Alterations in atrial and plasma atrial natriuretic factor (ANF) content during development of hypoxia-induced pulmonary hypertension in the rat. Proc Soc Exp Biol Med 1986:181:459-463.
26. Rogers TK, Stewart AG, Moricc AH: Effect of chronic hypoxia on rat pulmonary resistance vessels: Vasodilatation by atrial natriuretic peptide. Clin Sci 1992:83:723-729.
27. Rogers TK, Shccdy W, Waterhouse J. Howard P, Moricc AH: Haemodynamic effects of atrial natriuretic peptide in hypoxic chronic obstructive pulmonary disease. Thorax 1994:49:233-239.
28. Harris P, Gibson K. Glostcr J: Metabolic effects of chronic hypoxia on the myocardium. Bull Physio-Pathol Respir 1972:8:1408-1410.
29. Meyrick B. Perkett EA: Vascular smooth muscle hypertrophy and chronic pulmonary hypertension; in Widimsky J, Hcrget J (eds): Pulmonary Blood Vessels in Lung Disease. Basel, Karger. 1990. pp 29-38.
30. Russ RD. Walker BR: Maintained endothelium-dependent pulmonary vasodilation following chronic hypoxia in the rat. J Appl Physiol 1993;74:339-344